Bristol-Myers Squibb (BMY) Q4 2024 Earnings Call Transcript
Company Participants
- Operator
- Charles Triano - SVP & Head of Investor Relations, Bristol-Myers Squibb Company
- Christopher Boerner - CEO & Chairman, Bristol-Myers Squibb Company
- David Elkins - EVP & CFO, Bristol-Myers Squibb Company
- Chris Schott - Managing Director, JP Morgan
- Adam Lenkowsky - Executive VP, Chief Commercialization Officer & Head of U.S. Oncology, Bristol-Myers Squibb Company
- Christopher Boerner - CEO & Chairman, Bristol-Myers Squibb Company
- Charles Triano - SVP & Head of Investor Relations, Bristol-Myers Squibb Company
- Luisa Hector - Head of Global Pharma Equity Research, Berenberg
- Geoff Meacham - Managing Director, Citi
- Samit Hirawat - Executive VP & Chief Medical Officer of Drug Development, Bristol-Myers Squibb Company
- Chris Shibutani - Analyst, Goldman Sachs
- Tim Anderson - Managing Director, Senior Equity Research Analyst, Bank of America
- David Elkins - EVP & CFO, Bristol-Myers Squibb Company
- Mohit Bansal - Analyst, Wells Fargo
- Trung Huynh - Executive Director - Equity Research, UBS Group
- Evan Seigerman - MD & Senior Research Analyst, BMO Capital Markets
- Akash Tewari - Managing Director, Jefferies
- Terence Flynn - Equity Research Analyst, Morgan Stanley
- Courtney Breen - Senior Research Analyst, Bernstein
- Seamus Fernandez - Senior Managing Director, Guggenheim Partners
- David Risinger - Senior Managing Director & Senior Research Analyst, Leerink Partners
- Matthew Phipps - Group Head - Biotechnology, William Blair
- Steve Scala - Pharmaceutical Analyst, TD Cowen
- Kripa Devarakonda - Vice President - Equity Research, Truist Securities
- Olivia Brayer - Analyst, Cantor Fitzgerald
- James Shin - Director of Biopharma Equity Research, Deutsche Bank
- Sean McCutcheon - Vice President - Biotechnology Equity Research, Raymond James Financial
- Alexandria Hammond - Director, Head of Therapeutics, Wolfe Research LLC